Cantor Fitzgerald Upgrades Aclaris Therapeutis (ACRS) to Overweight

November 20, 2024 3:45 PM EST Send to a Friend
(Updated - November 20, 2024 3:46 PM EST)

Cantor Fitzgerald analyst Louise Chen upgraded Aclaris Therapeutis (NASDAQ: ACRS) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login